A small, privately-held, and family-focused neonatology pharmaceutical company, ONY Biotech is a leader in the creation of critically important products for the treatment of premature infants. We innovate with a singular purpose: to improve outcomes for premature babies and their families.
As a USA-born neonatology biotech, we take pride in the work we do delivering treatments that serve families here in the United States and around the world.
Company Details
- Employees
- 29
- Address
- 1576 Sweet Home Rd, Amherst,new York 14228-2710,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- onybiotech.com
- Keywords
- Infasurf® (calfactant), ONY Biotech’s primary commercial product, helps prevent and treat respiratory distress syndrome in newborns..
- HQ
- Amherst, New York
Ony Biotech Questions
Ony Biotech's website is onybiotech.com
Ony Biotech's LinkedIn profile is https://www.linkedin.com/company/onybiotech
Ony Biotech has
29 employees.
View email and phone details for 29
employees at Ony Biotech.
Ony Biotech's industry is
Pharmaceutical Manufacturing
Ony Biotech's top competitors are
Prugen Pharmaceuticals,
Ufc Biotechnology,
Genrx Pharmacy,
S1 Biopharma,
Chiesi Usa, Inc.,
Elgan Pharma,
Oak Hill Bio,
Zeptometrix,
Chiesi Group,
Athenex.
Ony Biotech's categories are Pharmaceutical Manufacturing
